BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹92 Cr | ₹100 Cr | ₹94 Cr | ₹75 Cr | ₹67 Cr |
What is the latest Sundry Debtors ratio of BAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹94 Cr |
| Mar2022 | ₹75 Cr |
| Mar2021 | ₹67 Cr |
How is Sundry Debtors of BAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -7.21 | |
| Mar2024 | ₹100 Cr | 6.01 | |
| Mar2023 | ₹94 Cr | 24.78 | |
| Mar2022 | ₹75 Cr | 12.08 | |
| Mar2021 | ₹67 Cr | - | |
Compare Sundry Debtors of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹130.3 Cr | 5.7% | 6.9% | -16.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 5.7% |
6.9% |
-16.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses